Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani

New treatments for visceral leishmaniasis, caused by Leishmania donovani, are needed to overcome sustained toxicity, cost, and drug resistance. The aim of this study was to evaluate the therapeutic effects of 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide (2NB) against promastigote and amastigote...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Drug Des Devel Ther
Autors principals: Dikhit, Manas R, Purkait, Bidyut, Singh, Ruby, Sahoo, Bikash Ranjan, Kumar, Ashish, Kar, Rajiv K, Ansari, Md Yousuf, Saini, Savita, Abhishek, Kumar, Sahoo, Ganesh C, Das, Sushmita, Das, Pradeep
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2016
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887065/
https://ncbi.nlm.nih.gov/pubmed/27307706
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S96650
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars